🇺🇸 ADT in United States

71 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dizziness — 13 reports (18.31%)
  2. Nausea — 11 reports (15.49%)
  3. Palpitations — 9 reports (12.68%)
  4. Malaise — 8 reports (11.27%)
  5. Hypoaesthesia — 7 reports (9.86%)
  6. Diarrhoea — 6 reports (8.45%)
  7. Headache — 5 reports (7.04%)
  8. Cerebrovascular Accident — 4 reports (5.63%)
  9. Gamma-Glutamyltransferase Increased — 4 reports (5.63%)
  10. Malignant Neoplasm Progression — 4 reports (5.63%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is ADT approved in United States?

ADT does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ADT in United States?

Canadian Cancer Trials Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.